Alpha2-adrenergic agonists for the reduction or discontinuation of opioids or opioid substitution therapy a review of clinical effectiveness and guidelines
Using alpha2-adrenergic agonists may be effective in opioid reduction or discontinuation relative to other supportive interventions or opioid substitution therapies. Further, there may be differences in effectiveness between alpha2-adrenergic agonists in themselves. This review considered the eviden...
Main Authors: | , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
2018, February 23, 2018
|
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | Using alpha2-adrenergic agonists may be effective in opioid reduction or discontinuation relative to other supportive interventions or opioid substitution therapies. Further, there may be differences in effectiveness between alpha2-adrenergic agonists in themselves. This review considered the evidence and guidelines to this effect, to explore whether alpha2-adrenergic agonists could assist in reducing the burden of opioid dependence |
---|---|
Physical Description: | 1 PDF file (26 pages) illustration |